Clinical Trial Update: Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

Phase II multicentric study evaluating pembrolizumab in classic or endemic Kaposi's sarcoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Kaposi Sarcoma, Progression, Disease | Phase 2 | Status: UNKNOWN